Seattle biotech startup backed by Gates Foundation launches trial for snail fever vaccine by Charlotte Schubert on May 31, 2022May 31, 2022 at 5:57 pm The first patient has been dosed with a vaccine for the tropical disease schistosomiasis, developed by Seattle biotech company PAI Life Sciences. The phase 1 trial will assess the safety… Read More